Ciclopropilamina refers to Derivatives of formula (i), where the ring a is aryl or heteroaryl C6 C10 5 to 10 members comprising up to 4 heteroatoms selected from N, o and S The Ring B is heterocicloalquilo 4 - 10 members including 3 heteroatoms selected from N, and S The cycloalkyl Ring C is monociclico C3 - C7.Heterocicloalquilo 4 to 7 members that includes up to 4 monocyclic heteroatoms selected from N, o and S, among others r1 is alkyl, Halo, C1 - C6, alquenilo C2 - C6, among others R2 is alkyl, Halo, C1 - C6, CN, among others R3 is c1-c6 alkyl, Halo, alquenilo C2 - C6, among others R4 is Halo, alkyd ILO C1 - C6, alquinilo C2 - C6, among others RZ is H, alkyl, Halo, C1 - C6, among others R5 and R6 are h,Halo, CN, among others, M and q are 0, 1 or 2 n and P is 0, 1, 2 or 3. Preferred compounds are: (1) - (4 - [(Trans - 2 - fenilciclopropil) amino] piperidin-1-yl cyclobutyl acetonitrile}) (1 - methyl - 3 - (4 - [(Trans - 2 - fenilciclopropil) piperidin-1-yl] amino} - 3 zetidin - il) acetonitrile among others. It also relates to a Pharmaceutical Composition and method of treatment.These compounds are inhibitors of LSD1, being useful in the treatment of cancerSe refiere a derivados de ciclopropilamina de formula (I), donde: el anillo A es arilo C6-C10 o heteroarilo de 5 a 10 miembros que comprende hasta 4 heteroatomos seleccionados de N, O y S el anillo B es heterocicloalquilo de 4-10 miembros que comprende hasta 3 heteroatomos seleccionados de N, O y S el anillo C es cicloalquilo C3-C7 monociclico, heterocicloalquilo de 4 a 7 miembros monociclicos que comprende hasta 4 heteroatomos seleccionados de N, O y S, entre otros R1 es halo, alquilo C1-C6, alquenilo C2-C6, entre otros R2 es halo, alquilo C1-C6, CN, entre otros R3 es halo, alquilo C1-C6, alquenilo C2-C6, entre otros R4 es halo, alquilo C1-C6, alquinilo C2-C6, entre otros RZ es H, halo, alquilo C1-C6, entre otros R5 y R6 son H, halo, CN, entre otros m y q son 0, 1 o 2 n y p son 0, 1, 2 o 3. Son compuestos prefe
